When you see the phrase “will be determined” on a medical report, insurance letter, benefits decision, or clinical document, it means a final answer hasn’t been reached yet and depends on specific criteria, test results, or evaluations still in progress. The phrase appears across many areas of healthcare, from lab results and cancer staging to disability claims and insurance approvals. In each case, a structured process with defined criteria drives the final outcome.
Lab Results Labeled “Indeterminate”
One of the most unsettling places to see a version of “will be determined” is on a lab report. When a test result comes back as indeterminate or inconclusive, it means the findings don’t clearly fit the criteria for either a positive or negative interpretation. This happens more often than most people realize, and it doesn’t necessarily mean something is wrong.
Indeterminate results can stem from three broad categories. The first is biological: your body may be in the early stages of an immune response (called seroconversion), meaning antibodies are present but not yet at detectable levels. Autoimmune conditions, other infections, or elevated levels of certain proteins can also create signals that mimic what the test is looking for without actually indicating the target disease. The second category is the test kit itself, which may have design limitations or interpretation thresholds that leave some samples in a gray zone. The third involves the testing process: cross-contamination, equipment variability, or how the sample was handled can all push a result into indeterminate territory. In most cases, your doctor will order a follow-up test, often using a different method or after waiting a few weeks for your immune response to develop further.
How Cancer Stage Is Determined
If you’ve been told your cancer stage “will be determined” after further testing, the process follows a standardized system called TNM staging. This is the most widely used cancer staging framework in the world, and it evaluates three things: the size of the primary tumor (T), whether cancer has reached nearby lymph nodes (N), and whether it has spread to distant parts of the body (M).
Each component gets a number reflecting severity. For the tumor, T1 through T4 indicates increasing size or growth into surrounding tissue. For lymph nodes, N0 means no cancer is found in nearby nodes, while N1 through N3 reflects increasing involvement. For metastasis, M0 means no distant spread, and M1 means the cancer has reached other organs. These three scores are combined into an overall stage from I to IV, with Stage IV indicating the cancer has spread to distant parts of the body. The staging process often requires imaging, lab work, and sometimes surgical biopsy before doctors can assign a final number, which is why you may hear that your stage is still being determined.
Drug Dosage Decisions
When a medication dose “will be determined” based on your individual profile, your care team is weighing several variables at once. The starting dose for any drug is based on how people with similar characteristics respond, then adjusted using your specific details: age, weight, gender, kidney function, liver function, and in some cases genetic factors that affect how quickly your body processes the drug.
Kidney function plays an especially large role. For drugs that leave the body primarily through the kidneys, doctors use formulas that factor in your age, weight, gender, and a blood marker called serum creatinine to estimate how well your kidneys are filtering. If your kidney function is reduced, the dose typically goes down. Liver function matters for drugs that are broken down by metabolic processes rather than filtered out. Age also has an independent effect: after about 40, the body’s ability to clear many medications gradually declines, and dosing formulas account for this. Weight influences dosing through a scaling principle where larger bodies generally need higher doses, but not in a simple one-to-one ratio.
Disability Benefits Evaluation
Social Security disability claims follow a strict five-step process, and at any step, the agency can make a final decision. If you’ve been told your disability status “will be determined,” your claim is moving through this sequence.
- Step 1: Are you currently working and earning above a set income threshold? If yes, you’re found not disabled regardless of your medical condition.
- Step 2: Is your impairment medically severe and expected to last at least 12 months? If not, the claim is denied.
- Step 3: Does your condition match or equal one of the agency’s listed impairments? If it does, you’re found disabled without further analysis.
- Step 4: Can you still perform the work you did in the past, given your remaining physical and mental abilities? If yes, you’re found not disabled.
- Step 5: Considering your remaining abilities, age, education, and work experience, can you adjust to other types of work? If not, you’re found disabled.
The process is sequential, meaning each step acts as a gate. Many claims stall at steps two through four while the agency gathers medical records, requests examinations, or evaluates your functional capacity in detail.
Insurance Coverage Decisions
When an insurer says coverage “will be determined,” they’re running your request through a medical necessity review. Medicare, for example, limits coverage to items and services that are reasonable and necessary for diagnosing or treating an illness or injury. Private insurers follow similar logic, though their specific criteria vary by plan.
National coverage decisions are made through an evidence-based process that sometimes includes outside technology assessments and input from advisory committees. For individual claims, your insurer compares your specific situation against clinical guidelines, the documented severity of your condition, and whether the proposed treatment falls within an approved benefit category. If the determination comes back as “not medically necessary,” you typically have the right to appeal, and appeals often succeed when additional clinical documentation is submitted.
Clinical Trial Eligibility
If your eligibility for a clinical trial “will be determined,” researchers are checking you against a detailed list of inclusion and exclusion criteria. Inclusion criteria specify what characteristics you must have, such as a particular disease stage or a specific genetic mutation the treatment targets. Exclusion criteria disqualify participants based on factors like other health conditions, medications you’re taking, or organ function that falls outside acceptable ranges.
These criteria can be surprisingly restrictive. In one FDA review of 38 drug trials, more than 60% excluded patients based on liver enzyme levels, 58% excluded based on kidney function, and 37% excluded based on a specific kidney blood marker. Older adults are also frequently underrepresented: about 27% of clinical trials for diseases common in older populations excluded participants based on age alone, despite FDA guidance dating back to the 1980s urging their inclusion. Around 60% of American adults have at least one chronic condition, and 42% of those have multiple chronic conditions, which means a large portion of the real-world patient population faces barriers to trial participation.
Surgical Fitness Assessment
Before any surgery, your physical status is classified on a six-level scale developed by the American Society of Anesthesiologists. This classification helps determine whether you’re a candidate for a procedure, what level of monitoring you’ll need, and what risks to plan for.
A Class 1 rating means you’re a healthy patient with no systemic disease. Class 2 indicates mild systemic disease. Class 3 means severe systemic disease that isn’t immediately life-threatening. Class 4 is reserved for severe disease that poses a constant threat to life. Class 5 applies to patients not expected to survive without the operation. Class 6 is a designation for brain-dead patients whose organs are being recovered for transplant. Most elective surgeries proceed with patients in Classes 1 through 3, while Classes 4 and 5 typically involve emergency or high-risk situations where the surgical team weighs the danger of operating against the danger of not operating.
Transplant Priority Ranking
For patients awaiting a liver transplant, priority on the national waiting list is determined by a numerical score that reflects how urgently you need the organ. This score, called the MELD score, uses three blood test results: bilirubin (which reflects how well your liver processes waste), creatinine (which reflects kidney function, often impaired in advanced liver disease), and a clotting measure called INR that indicates how well your blood coagulates.
The score ranges up to 40, with higher numbers indicating more severe illness and greater urgency. The system was adopted in 2002 to replace a model that prioritized time spent on the waiting list, shifting instead to transplanting the sickest patients first. Creatinine values are capped at a maximum of 4 and a minimum of 1 within the formula to prevent extreme values from skewing the score. Patients who have received dialysis at least twice in the previous week are automatically assigned the maximum creatinine value. Low sodium levels in the blood also predict increased risk of death on the waiting list, with mortality rising about 5% for each unit of sodium decrease between 125 and 140, independent of the MELD score itself.